- Home
- NVNI vs DARE Comparison
NVNI vs DARE Comparison
Compare NVNI & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNI
- DARE
- Stock Information
- Founded
- NVNI 2019
- DARE 2015
- Country
- NVNI Brazil
- DARE United States
- Employees
- NVNI N/A
- DARE N/A
- Industry
- NVNI
- DARE Biotechnology: Pharmaceutical Preparations
- Sector
- NVNI
- DARE Health Care
- Exchange
- NVNI Nasdaq
- DARE Nasdaq
- Market Cap
- NVNI 31.5M
- DARE 26.3M
- IPO Year
- NVNI N/A
- DARE N/A
- Fundamental
- Price
- NVNI $0.35
- DARE $2.52
- Analyst Decision
- NVNI
- DARE Strong Buy
- Analyst Count
- NVNI 0
- DARE 3
- Target Price
- NVNI N/A
- DARE $12.50
- AVG Volume (30 Days)
- NVNI 1.3M
- DARE 443.5K
- Earning Date
- NVNI 08-07-2025
- DARE 08-11-2025
- Dividend Yield
- NVNI N/A
- DARE N/A
- EPS Growth
- NVNI N/A
- DARE N/A
- EPS
- NVNI N/A
- DARE N/A
- Revenue
- NVNI $31,250,627.00
- DARE $25,909.00
- Revenue This Year
- NVNI $12.05
- DARE $99,756.91
- Revenue Next Year
- NVNI $15.02
- DARE $119.77
- P/E Ratio
- NVNI N/A
- DARE N/A
- Revenue Growth
- NVNI 1491.58
- DARE N/A
- 52 Week Low
- NVNI $0.14
- DARE $2.11
- 52 Week High
- NVNI $12.19
- DARE $4.60
- Technical
- Relative Strength Index (RSI)
- NVNI 53.38
- DARE 41.75
- Support Level
- NVNI $0.28
- DARE $2.37
- Resistance Level
- NVNI $0.38
- DARE $2.54
- Average True Range (ATR)
- NVNI 0.03
- DARE 0.14
- MACD
- NVNI 0.01
- DARE -0.00
- Stochastic Oscillator
- NVNI 74.21
- DARE 59.56
About NVNI Nvni Group Limited
Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.